Osaic Holdings
VRAX icon

Osaic Holdings’s Virax Biolabs VRAX Stock Holding History

Osaic Holdings’s Portfolio VRAX Stock Details VRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Hold
1
– – ﹤0.01% 7766
2025
Q4 		$7 Buy
+1
New +$13 ﹤0.01% 7771

Other funds holding VRAX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Osaic Holdings's VRAX Position: Q1 2026 in Review

Osaic Holdings held its Virax Biolabs (VRAX) position steady in Q1 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #7766.

Osaic Holdings first reported a position in VRAX in Q4 2025 and has held it in 2 quarters since. The position peaked at $7 in Q4 2025. 4 funds tracked by Wall St. Rank hold VRAX as of Q1 2026.

  • Osaic Holdings held 1 share of Virax Biolabs worth $4 as of Q1 2026.
  • Osaic Holdings left its Virax Biolabs share count unchanged in Q1 2026.
  • Virax Biolabs made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7766 holding.
  • Osaic Holdings first reported a position in Virax Biolabs in Q4 2025 and has held it in 2 quarters since.
  • Osaic Holdings's Virax Biolabs position peaked at $7 in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Virax Biolabs as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.